Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for HRMY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 373.84M
March 31, 2026 361.48M
December 31, 2025 401.41M
September 30, 2025 373.10M
June 30, 2025 334.93M
March 31, 2025 335.01M
December 31, 2024 340.04M
September 30, 2024 331.33M
June 30, 2024 319.80M
March 31, 2024 331.59M
December 31, 2023 344.46M
September 30, 2023 296.43M
June 30, 2023 275.01M
March 31, 2023 272.05M
Date Value
December 31, 2022 271.03M
September 30, 2022 299.58M
June 30, 2022 258.50M
March 31, 2022 249.50M
December 31, 2021 246.94M
September 30, 2021 239.07M
June 30, 2021 233.14M
March 31, 2021 229.37M
December 31, 2020 329.89M
September 30, 2020 225.52M
June 30, 2020 652.18M
March 31, 2020 635.42M
December 31, 2019 529.56M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Liquidia Corp. 326.80M
Repligen Corp. 838.15M
Johnson & Johnson 116.09B
ACADIA Pharmaceuticals, Inc. 436.29M
ANI Pharmaceuticals, Inc. 896.90M

Total Liabilities (Quarterly) Related Metrics